Ray Dalio Bridgewater Associates
Ray Dalio is the founder of Bridgewater Associates, one of the world’s largest hedge funds, known for its unique “principles-based” culture and systematic investment approach. Dalio’s investment philosophy emphasizes diversified portfolios, risk parity, and the importance of understanding economic cycles in shaping investment decisions. He has authored several books, including “Principles: Life & Work,” in which he details his management philosophies, personal experiences, and life lessons.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$118M |
| 2 |
JPMorgan Chase
JPM
|
+$87.7M |
| 3 |
Bank of America
BAC
|
+$66.7M |
| 4 |
Citigroup
C
|
+$58.3M |
| 5 |
Wells Fargo
WFC
|
+$33.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$227M |
| 2 |
Johnson & Johnson
JNJ
|
+$198M |
| 3 |
Coca-Cola
KO
|
+$184M |
| 4 |
PepsiCo
PEP
|
+$179M |
| 5 |
McDonald's
MCD
|
+$141M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 27.91% |
| 2 | Healthcare | 19.75% |
| 3 | Financials | 10.48% |
| 4 | Consumer Discretionary | 9.62% |
| 5 | Communication Services | 3.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Neogen
NEOG
$2.5B
| $3.57M | 0.02% |
234,620
-75,079
| -24% | -$1.07M |
|
427
Guardant Health
GH
$22.6B
| $3.5M | 0.02% |
128,546
-30,917
| -19% | -$1.41M |
|
428
J&J Snack Foods
JJSF
$1.71B
| $3.48M | 0.02% |
23,230
-7,469
| -24% | -$1.11M |
|
|
DOCU
429
DocuSign
DOCU
$11.5B
| $3.47M | 0.02% |
62,637
+57,446
| +1,107% | +$2.8M |
|
|
MOMO
430
Hello Group
MOMO
$866M
| $3.46M | 0.02% |
385,799
-14,324
| -4% | -$84.9K |
|
431
Reynolds Consumer Products
REYN
$5.59B
| $3.46M | 0.02% |
115,529
-37,083
| -24% | -$1.11M |
|
432
Hain Celestial
HAIN
$53.7M
| $3.46M | 0.02% |
214,063
-42,206
| -16% | -$752K |
|
433
Brunswick
BC
$5.28B
| $3.45M | 0.02% |
47,881
-64,668
| -57% | -$4.6M |
|
434
Gentex
GNTX
$5.07B
| $3.45M | 0.02% |
126,464
+105,661
| +508% | +$2.82M |
|
435
3M
MMM
$94.3B
| $3.45M | 0.02% |
34,392
+9,945
| +41% | +$1.01M |
|
436
Phreesia
PHR
$773M
| $3.42M | 0.02% |
105,809
-33,117
| -24% | -$899K |
|
437
Tandem Diabetes Care
TNDM
$1.56B
| $3.41M | 0.02% |
75,847
-25,896
| -25% | -$1.17M |
|
438
Ares Capital
ARCC
$14.4B
| $3.39M | 0.02% |
183,668
+41,836
| +29% | +$786K |
|
439
East-West Bancorp
EWBC
$18B
| $3.39M | 0.02% |
51,375
+17,008
| +49% | +$1.16M |
|
|
AMED
440
DELISTED
Amedisys
AMED
| $3.36M | 0.02% |
40,203
-10,966
| -21% | -$989K |
|
441
Affiliated Managers Group
AMG
$9.76B
| $3.34M | 0.02% |
21,100
-31,414
| -60% | -$4.44M |
|
442
Broadridge
BR
$19B
| $3.33M | 0.02% |
+24,822
| New | +$3.53M |
|
443
Shake Shack
SHAK
$2.87B
| $3.29M | 0.02% |
79,275
-25,430
| -24% | -$1.24M |
|
444
Weis Markets
WMK
$1.86B
| $3.29M | 0.02% |
40,002
-8,773
| -18% | -$740K |
|
445
Ross Stores
ROST
$81.9B
| $3.29M | 0.02% |
28,315
-5,827
| -17% | -$594K |
|
|
NARI
446
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $3.26M | 0.02% |
51,226
-16,732
| -25% | -$1.21M |
|
447
iRhythm Holdings
IRTC
$4.2B
| $3.23M | 0.02% |
34,465
-11,794
| -25% | -$1.28M |
|
448
Revvity
RVTY
$12.8B
| $3.21M | 0.02% |
22,874
-6,870
| -23% | -$924K |
|
449
Ovintiv
OVV
$16.4B
| $3.16M | 0.02% |
+62,296
| New | +$3.26M |
|
|
SBNY
450
DELISTED
Signature Bank
SBNY
| $3.14M | 0.02% |
27,287
+12,071
| +79% | +$1.66M |
|
Similar funds
Ray Dalio's Q4 2022 Portfolio in Review
As of Q4 2022, Ray Dalio held 953 positions worth $18.3B, down 7.3% from $19.8B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Ray Dalio withdrew a net $3.25B in Q4 2022, closing 133 positions and reducing 457 holdings. Its most notable exit was Advanced Micro Devices, an estimated $45.8M position sold in full.
By sector, the portfolio is most concentrated in Consumer Staples at 28% of assets, down from 30% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Ray Dalio opened a new position in JPMorgan Chase worth $92.8M.
- Ray Dalio's largest Q4 2022 buy was JPMorgan Chase: 692,356 shares worth $92.8M.
- Ray Dalio added most to iShares Core S&P 500 ETF in Q4 2022, an estimated $118M increase.
- Ray Dalio's biggest Q4 2022 reduction was Procter & Gamble, cutting an estimated $227M.
- Ray Dalio fully exited Advanced Micro Devices in Q4 2022, selling an estimated $45.8M.
- Ray Dalio's ten largest holdings make up 32% of its $18.3B portfolio in Q4 2022.
- Ray Dalio opened 87 new positions and closed 133 in Q4 2022.
- Ray Dalio's portfolio value fell 7.3% quarter-over-quarter to $18.3B.
Based on Bridgewater Associates's 13F filing for Q4 2022, filed 13 Feb 2023.